CHARLES W NEWHALL III Insider Trading $PARS PHARMOS CORP
Get free email notifications about insider trading for CHARLES W NEWHALL III.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES W NEWHALL III. CHARLES W NEWHALL III is Director in PHARMOS CORP ($PARS) and 10% Owner in APPLIED IMAGING CORP ($AICX) and 10% Owner in ARADIGM CORP ($ARDM) and 10% Owner in NETSOLVE INC ($NTSL) and 10% Owner in ZTI MERGER SUBSIDIARY III INC ($ZHNE) and 10% Owner in OCCAM NETWORKS INC/DE ($OCCM) and in ZHONE TECHNOLOGIES INC ($ZHNE) and 10% Owner in ZHONE TECHNOLOGIES INC ($ZHNE) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and in MYOGEN INC ($MYOG) and 10% Owner in MYOGEN INC ($MYOG) and in PHARMION CORP ($PHRM) and 10% Owner in PHARMION CORP ($PHRM) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and 10% Owner in FOXHOLLOW TECHNOLOGIES, INC. ($FOXH) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in VONAGE HOLDINGS CORP ($VG) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in INNERWORKINGS INC ($INWK) and Director in SUPERNUS PHARMACEUTICALS INC ($SUPN).
CHARLES W NEWHALL III in PHARMOS CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CHARLES W NEWHALL III: Director
Holdings: 14,435,105 shares
Current Value: $288,702
Latest Transaction: Jul 06 2009
$PARS Market Capitalization: $1.11M
$PARS Previous Close: $0.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CHARLES W NEWHALL III in PHARMOS CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FOLD, AICX, ARDM, CBIO, DZSI, FOXH, INHX, INWK, IOMI, MYOG, NTSL, OCCM, PRTK, PHRM, PARS, SUPN, VTAE, VG, ZHNE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.24 | 25,000 | 6,000 | 25,000 | |
| May 12 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.05 | 543,427 | 29,345 | 14,435,105 | 13.9 M to 14.4 M (+3.91 %) |
| Apr 23 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.12 | 8,000,000 | 960,000 | 8,000,000 | |
| Apr 23 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.28 | 3,636,364 | 1,000,000 | 13,891,678 | 10.3 M to 13.9 M (+35.46 %) |
| Apr 23 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.10 | 8,000,000 | 800,000 | 10,176,488 | 2.2 M to 10.2 M (+367.56 %) |
| Jan 16 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.14 | 22,500 | 3,150 | 22,500 | |
| Jan 16 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.34 | 147,059 | 50,000 | 2,176,488 | 2 M to 2.2 M (+7.25 %) |
| Jul 18 2008 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.36 | 148,605 | 53,201 | 2,029,429 | 1.9 M to 2 M (+7.90 %) |
| Jul 02 2008 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.39 | 22,500 | 8,775 | 22,500 | |
| Jan 25 2008 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.35 | 22,500 | 7,875 | 22,500 | |
| Jan 19 2007 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 |
Page: 1